Roche, the manufacturer of Tamiflu, has made it impossible for scientists to assess how well the anti-flu drug works by withholding the evidence the company has gained from trials, doctors alleged on Tuesday.
A major review of what data there is in the public domain has found no evidence Tamiflu can prevent healthy people with flu from suffering complications such as pneumonia.
Tamiflu may shorten the bout of illness by a day or so, the investigators say, but it is impossible to know whether it prevents severe disease because the published data is insufficient. Roche has failed to make some of the studies carried out on the drug publicly available, the scientists say.
“Governments around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge,” said Fiona Godlee, editor of the British Medical Journal, which published the new review online and collaborated in a joint investigation with Channel 4 News, shown on Tuesday night.
Roche has made a fortune out of the drug, with sales of £1.6 billion this year alone.
In the review, Chris Del Mar, from Bond University in Australia, analyzed 20 published trials that focused on prevention, treatment and adverse reactions. The authors say they were hampered by the “paucity of good data.”
The reviewers were forced to leave out eight trials because they had not been published, and Roche offered them “under conditions we thought unacceptable, and what was offered to us was insufficient to analyze properly.”
As they did not have full access to all the trials, the reviewers say previous evidence on the effects of Tamiflu and other drugs of this class [the neuraminidase inhibitors] may be unreliable. They call on governments to set up studies to monitor the drugs for safety.
A second review was carried out at Birmingham University, England, by Nick Freemantle and Melanie Calvert, who analyzed a series of observational studies Roche provided. These are studies of people who took the drugs, but without a comparison group of people who did not take them.
Although the reviewers had doubts about the data, they say it is possible Tamiflu reduced the risk of pneumonia. But if so, the benefit was small and there were side-effects to consider.
Freemantle said he saw “very little evidence to support the widespread use of oseltamivir in the otherwise healthy population who are developing signs of influenza-like illness.”
He added: “We have remarkably few resources in this country [the UK] to spend on pharmaceuticals on health, and it is surprising to see such widespread use of oseltamivir. But I suppose that once you’ve gone and bought lots of doses, then it’s a bit like the situation with gun control in the US. If you have a gun in the house, it is much easier to use it. But it does not mean it’s the right thing to do.”
Godlee and Mike Clarke, director of the UK Cochrane Centre, call, in the BMJ, for new global legislation to ensure all trial data on drugs that have been granted a licence must be published in full.
Roche said that it firmly believed in the robustness of the data. It said governments and licensing authorities had been given access to all the trial information.
Roche has now undertaken to put summaries of all the Tamiflu study data on a password-protected site.
CONFRONTATION: The water cannon attack was the second this month on the Philippine supply boat ‘Unaizah May 4,’ after an incident on March 5 The China Coast Guard yesterday morning blocked a Philippine supply vessel and damaged it with water cannons near a reef off the Southeast Asian country, the Philippines said. The Philippine military released video of what it said was a nearly hour-long attack off the Second Thomas Shoal (Renai Shoal, 仁愛暗沙) in the contested South China Sea, where Chinese ships have unleashed water cannons and collided with Philippine vessels in similar standoffs in the past few months. The China Coast Guard and other vessels “once again harassed, blocked, deployed water cannons, and executed dangerous maneuvers” against a routine rotation and resupply mission to
GLOBAL COMBAT AIR PROGRAM: The potential purchasers would be limited to the 15 nations with which Tokyo has signed defense partnership and equipment transfer deals Japan’s Cabinet yesterday approved a plan to sell future next-generation fighter jets that it is developing with the UK and Italy to other nations, in the latest move away from the country’s post-World War II pacifist principles. The contentious decision to allow international arms sales is expected to help secure Japan’s role in the joint fighter jet project, and is part of a move to build up the Japanese arms industry and bolster its role in global security. The Cabinet also endorsed a revision to Japan’s arms equipment and technology transfer guidelines to allow coproduced lethal weapons to be sold to nations
Thousands of devotees, some in a state of trance, gathered at a Buddhist temple on the outskirts of Bangkok renowned for sacred tattoos known as Sak Yant, paying their respects to a revered monk who mastered the practice and seeking purification. The gathering at Wat Bang Phra Buddhist temple is part of a Thai Wai Khru ritual in which devotees pay homage to Luang Phor Pern, the temple’s formal abbot, who died in 2002. He had a reputation for refining and popularizing the temple’s Sak Yant tattoo style. The idea that tattoos confer magical powers has existed in many parts of Asia
ON ALERT: A Russian cruise missile crossed into Polish airspace for about 40 seconds, the Polish military said, adding that it is constantly monitoring the war to protect its airspace Ukraine’s capital, Kyiv, and the western region of Lviv early yesterday came under a “massive” Russian air attack, officials said, while a Russian cruise missile breached Polish airspace, the Polish military said. Russia and Ukraine have been engaged in a series of deadly aerial attacks, with yesterday’s strikes coming a day after the Russian military said it had seized the Ukrainian village of Ivanivske, west of Bakhmut. A militant attack on a Moscow concert hall on Friday that killed at least 133 people also became a new flash point between the two archrivals. “Explosions in the capital. Air defense is working. Do not